SIBEL, Belgium's sole surgical instrument manufacturer, has been successfully acquired through a Management Buy-Out led by key management members, securing its local heritage while promising future growth.

Target Company Overview

SIBEL, the sole Belgian manufacturer of surgical instruments, has successfully completed a Management Buy-Out (MBO) led by key members of its management team. Founded by Olivier Rouvez, the company is headquartered in Gembloux and is renowned for its exceptional industrial craftsmanship, with over 90% of its production earmarked for export. SIBEL enjoys a strong international reputation, providing high-quality surgical instruments that are integral to medical procedures worldwide.

The MBO sees Marie and Rémi Bertrand, who have been integral to the company's operations, joined by their brother Tanguy as they take over the reins from Rouvez. This transition reflects not only a continuation of the family's legacy within the company but also a commitment to preserving local expertise and innovation rather than allowing the business to fall into foreign hands.

Industry Overview in Belgium

Belgium's medical device industry is characterized by a strong emphasis on innovation and quality, positioning it as one of the leading markets in Europe. The country boasts a ro

View Source

Similar Deals

LDC Taking Care

2025

Management Buyout / Buy-In (MBO) Home Healthcare Services United Kingdom
CPF Living Communities Rivertown Ridge

2025

Management Buyout / Buy-In (MBO) Residential & Long-Term Care United States of America
Dienstenthuis Domocura

2025

Other Healthcare Facilities & Services (NEC) Belgium
Three buying groups The Joint Corp.

2025

Management Buyout / Buy-In (MBO) Alternative Medicine Facilities United States of America
KKA Partners BLACKROLL

2025

Management Buyout / Buy-In (MBO) Advanced Medical Equipment & Technology (NEC) Switzerland
Color セントケア・ホールディング

2025

Management Buyout / Buy-In (MBO) Home Healthcare Services Japan

Marie et Rémi Bertrand, Tanguy Bertrand

invested in

SIBEL

in 2024

in a Management Buyout / Buy-In (MBO) deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert